These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10920297)

  • 21. In vitro cytotoxicity and teratogenicity of norethisterone and levonorgestrel released from hollow nylon monofilaments.
    Ostad SN; Malhi JS; Gard PR
    J Control Release; 1998 Jan; 50(1-3):179-86. PubMed ID: 9685884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24/4 regimen.
    Duijkers IJ; Heger-Mahn D; Drouin D; Skouby S
    Eur J Contracept Reprod Health Care; 2015; 20(6):419-27. PubMed ID: 26073333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental study of cervical blockage induced by continuous low-dose oral progestogens.
    Chretien FC; Sureau C; Neau C
    Contraception; 1980 Nov; 22(5):445-56. PubMed ID: 6894112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of norethisterone acetate with or without ethinyl oestradiol on the sialic acid concentration and sperm receptivity of the cervical mucus.
    Carlborg L; McCormick W; Gemzell C
    Acta Endocrinol (Copenh); 1968 Dec; 59(4):636-43. PubMed ID: 5757032
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of norethisterone and levonorgestrel in low-dose multiphasic oral contraceptives on serum lipids.
    Wiik P; Nordby J; Paulsen JE
    Acta Obstet Gynecol Scand; 1993 Oct; 72(7):550-5. PubMed ID: 8213103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of protease inhibitors on the cervical mucus of HIV-positive women taking norethindrone contraception.
    Atrio J; Stek A; Vora H; Sanchez-Keeland L; Zannat F; Natavio M
    Eur J Contracept Reprod Health Care; 2015 Apr; 20(2):149-53. PubMed ID: 25285572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biphasic versus triphasic oral contraceptives for contraception.
    Van Vliet H; Grimes D; Helmerhorst F; Schulz K
    Cochrane Database Syst Rev; 2001; (4):CD003283. PubMed ID: 11687185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
    Edelman AB; Koontz SL; Nichols MD; Jensen JT
    Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human cervical mucus during the menstrual cycle and pregnancy in normal and pathological conditions.
    Chretien FC; Cohen J; Borg V; Psychoyos A
    J Reprod Med; 1975 May; 14(5):192-6. PubMed ID: 1142355
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment with Norplant subdermal implants inhibits sperm penetration through cervical mucus in vitro.
    Croxatto HB; Díaz S; Salvatierra AM; Morales P; Ebensperger C; Brandeis A
    Contraception; 1987 Aug; 36(2):193-201. PubMed ID: 3123133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Some effects of hormonal contraceptives on the mammary tissue. Influence of duration of use and age os user].
    de Sampaio Junior LF; Stecca J; Neme B
    Matern Infanc (Sao Paulo); 1974; 33(4):509-30. PubMed ID: 4470961
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-acting hormonal contraceptives for women.
    Garza-Flores J; Hall PE; Perez-Palacios G
    J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biphasic versus triphasic oral contraceptives for contraception.
    Van Vliet HA; Grimes DA; Helmerhorst FM; Schulz KF
    Cochrane Database Syst Rev; 2003; (2):CD003283. PubMed ID: 12804457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of four combined oral contraceptives on blood pressure in the pill-free interval.
    Nichols M; Robinson G; Bounds W; Newman B; Guillebaud J
    Contraception; 1993 Apr; 47(4):367-76. PubMed ID: 8508666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones.
    Franklin RD; Kutteh WH
    J Reprod Immunol; 1999 Mar; 42(2):93-106. PubMed ID: 10221733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability.
    Lewis RA; Taylor D; Natavio MF; Melamed A; Felix J; Mishell D
    Contraception; 2010 Dec; 82(6):491-6. PubMed ID: 21074010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preclinical research and development of norethisterone].
    Mcguire JL; Hahn DW; Philipps A
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF; Crook D; Devenport M; Wynn V
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months.
    Spellacy WN; Ellingson AB; Kotlik A; Tsibris JC
    Am J Obstet Gynecol; 1988 Oct; 159(4):877-9. PubMed ID: 3052079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.